Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Pfizer Inc.
EIR
•Pfizer Inc.•September 28, 2022

Pfizer Inc. – FDA EIR, Sep 28, 2022

Record Details

An FDA inspection was conducted at Pfizer Inc.'s Parsippany, NJ facility from September 26 to September 28, 2022. This inspection, initiated as per the FY’23 workplan and MRA Inspection Request, focused on the control testing laboratory's drug product testing activities, including for Litfulo (ritlecitinib). The regulatory framework for the inspection adhered to Compliance Program 7356.002, Drug Manufacturing Inspections, and comprehensively covered the firm’s Quality and Laboratory Control Systems, alongside overall Good Manufacturing Practices (GMP) operations. The Parsippany site functions as a crucial control testing laboratory for various Pfizer locations, providing scientific and analytical support, including stability study management, sample testing for Active Pharmaceutical Ingredients (API) and marketed products, and investigations into out-of-specification data. Notably, the inspection concluded without identifying any objectionable conditions. As a result, no Form FDA-483, Inspectional Observations, was issued, signifying that the facility was found to be operating in compliance with applicable regulatory standards. Consequently, no specific violations or required actions were documented for Pfizer Inc. stemming from this assessment.

Company
Pfizer Inc.
Inspection date
September 28, 2022
Product type
drugs
Office
New Jersey District Office
People
  • Robin P. Mathew
  • Monika Borkowska (investigator)
  • Victoria Spivak (Pharmacist | Consumer Safety Officer)
View Company Profile

ID · e5c7bb44-06ce-4ca8-b264-c3d433519b9b

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pfizer Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.